BioCentury
ARTICLE | Clinical News

Aezea cenersen sodium regulatory update

October 20, 2008 7:00 AM UTC

EMEA's Committee for Orphan Medicinal Products (COMP) issued a positive opinion to grant Orphan Drug designation for Aezea cenersen to treat chronic lymphocytic leukemia (CLL). The antisense oligonucl...